Tenon Medical, Inc. Operating Lease Cost
Tenon Medical, Inc. (TNON) reported Operating Lease Cost of $95.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-13
- Tenon Medical, Inc. operating lease, cost for the quarter ending 2026-06-30 was $95.00K, a 30.14% increase year-over-year.
- Tenon Medical, Inc. operating lease, cost for the quarter ending 2026-03-31 was $76.00K, a 4.11% increase year-over-year.
- Tenon Medical, Inc. operating lease, cost for the quarter ending 2025-12-31 was $76.00K, a 4.11% increase year-over-year.
- Tenon Medical, Inc. operating lease, cost for the quarter ending 2025-09-30 was $73.00K, a 0.00% change year-over-year.
- Tenon Medical, Inc. operating lease, cost for fiscal 2025 was $292.00K, a 0.00% change from fiscal 2024.
- Tenon Medical, Inc. operating lease, cost for fiscal 2024 was $292.00K, a 0.00% change from fiscal 2023.
- Tenon Medical, Inc. operating lease, cost for fiscal 2023 was $292.00K, a 0.00% change from fiscal 2022.
- Tenon Medical, Inc. operating lease, cost for fiscal 2022 was $292.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $95.00K 10-Q · filed 2026-08-13 | $171.00K 10-Q · filed 2026-08-13 | $247.00K derived: sum of 3 quarters · filed 2026-08-13 | $320.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $76.00K 10-Q · filed 2026-05-15 | $152.00K derived: sum of 2 quarters · filed 2026-05-15 | $225.00K derived: sum of 3 quarters · filed 2026-05-15 | $298.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $149.00K derived: sum of 2 quarters · filed 2026-03-27 | $222.00K derived: sum of 3 quarters · filed 2026-08-13 | $292.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $73.00K 10-Q · filed 2025-11-13 | $146.00K derived: sum of 2 quarters · filed 2026-08-13 | $216.00K 10-Q · filed 2025-11-13 | $292.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $73.00K 10-Q · filed 2026-08-13 | $146.00K 10-Q · filed 2026-08-13 | $219.00K derived: sum of 3 quarters · filed 2026-08-13 | $292.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $73.00K 10-Q · filed 2026-05-15 | $146.00K derived: sum of 2 quarters · filed 2026-05-15 | $219.00K derived: sum of 3 quarters · filed 2026-05-15 | $292.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $146.00K derived: sum of 2 quarters · filed 2026-03-27 | $219.00K derived: sum of 3 quarters · filed 2026-03-27 | $292.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $73.00K 10-Q · filed 2025-11-13 | $146.00K derived: sum of 2 quarters · filed 2025-11-13 | $219.00K 10-Q · filed 2025-11-13 | $292.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $73.00K 10-Q · filed 2025-08-13 | $146.00K 10-Q · filed 2025-08-13 | $219.00K derived: sum of 3 quarters · filed 2025-08-13 | $292.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $73.00K 10-Q · filed 2025-05-13 | $146.00K derived: sum of 2 quarters · filed 2025-05-13 | $219.00K derived: sum of 3 quarters · filed 2025-05-13 | $292.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $146.00K derived: sum of 2 quarters · filed 2025-03-26 | $219.00K derived: sum of 3 quarters · filed 2025-03-26 | $292.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $73.00K 10-Q · filed 2024-11-14 | $146.00K derived: sum of 2 quarters · filed 2024-11-14 | $219.00K 10-Q · filed 2024-11-14 | $292.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $73.00K 10-Q · filed 2024-08-13 | $146.00K 10-Q · filed 2024-08-13 | $219.00K derived: sum of 3 quarters · filed 2024-08-13 | $292.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $73.00K 10-Q · filed 2024-05-15 | $146.00K derived: sum of 2 quarters · filed 2024-05-15 | $219.00K derived: sum of 3 quarters · filed 2024-05-15 | $292.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $146.00K derived: sum of 2 quarters · filed 2024-03-29 | $219.00K derived: sum of 3 quarters · filed 2024-03-29 | $292.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $73.00K 10-Q · filed 2023-11-14 | $146.00K derived: sum of 2 quarters · filed 2023-11-14 | $219.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $73.00K 10-Q · filed 2023-08-11 | $146.00K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |